First read for a new ticker takes about 20–30 seconds while we build the analysis from the latest fundamentals, estimates, and intelligence. It's saved after this, so future visits are instant.
Thesis: SSE: the story is balanced — UK regulatory decisions on allowed returns (WACC) and capex allowances under RIIO price control reviews - 25-50bp WACC…
★ Analysts see FY2027 revenue reaching $11.3B — +11.0% growth in a single year.
What Moves the Stock
1UK regulatory decisions on allowed returns (WACC) and capex allowances under RIIO price control reviews - 25-50bp WACC changes materially impact valuation
2Renewable generation output and UK wholesale power prices - wind capacity factors and £/MWh baseload prices drive earnings volatility
3Progress on major capital projects (Dogger Bank offshore wind phases, SSEN Transmission upgrades) - construction milestones and commissioning timelines
4UK energy policy developments on grid investment funding, contracts-for-difference auctions, and net-zero infrastructure support
5Sterling exchange rate movements - impacts translation of UK earnings for international investors
6Regulated electricity networks (transmission/distribution) - estimated 60-65% of EBITDA, earning allowed returns on ~£10B+ regulated asset base
7Renewable generation (wind/hydro) - estimated 25-30% of EBITDA, selling power via PPAs and merchant exposure
High sensitivity through multiple channels: (1) Regulatory WACC calculations incorporate risk-free rates and debt costs…
Watch on earnings: UK wholesale baseload power prices (£/MWh) - drives renewable generation profitability and merchant exposure, UK 10-year gilt yields - proxy for regulatory WACC calculations and utility valuation multiples, GBP/USD exchange rate - impacts dollar-based investor returns and international competitiveness.
One Sentence Summary:
SSE: the story is balanced — uk regulatory decisions on allowed returns (wacc) and capex allowances under riio price control reviews - 25-50bp wacc changes materially.
Auto-composed from Stock Alarm intelligence, financial statements, and analyst estimates. Not investment advice.